Enfusion (ENFN) Insider Trading & Ownership $10.63 +0.16 (+1.53%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Enfusion (NYSE:ENFN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.44%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$576,233.53 Get ENFN Insider Trade Alerts Want to know when executives and insiders are buying or selling Enfusion stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ENFN Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Enfusion Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2024Neal PawarCOOSell21,801$10.03$218,664.03 10/22/2024Matthew CampobassoGeneral CounselSell674$8.95$6,032.30 6/20/2024Bronwen BastoneInsiderSell18,241$8.11$147,934.51 6/18/2024Bronwen BastoneInsiderSell10,539$8.17$86,103.63 6/18/2024Matthew CampobassoGeneral CounselSell1,651$8.17$13,488.67 6/18/2024Valeria GutowskiCAOSell1,258$8.17$10,277.86 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/14/2024Deirdre SomersDirectorSell4,629$8.40$38,883.60 2/29/2024Matthew CampobassoGeneral CounselSell108$8.73$942.84 2/29/2024Valeria GutowskiCAOSell27$8.73$235.71 1/10/2024Deirdre SomersDirectorSell1,770$8.65$15,310.50 1/8/2024Bradley HerringCFOSell1,998$9.23$18,441.54 1/8/2024Bronwen BastoneInsiderSell391$9.23$3,608.93 1/8/2024Matthew CampobassoGeneral CounselSell472$9.23$4,356.56 1/8/2024Oleg MovchanCEOSell1,295$9.23$11,952.85 (Data available from 1/1/2013 forward) ENFN Insider Trading Activity - Frequently Asked Questions Who is on Enfusion's Insider Roster? The list of insiders at Enfusion includes Bradley Herring, Bronwen Bastone, Dan Groman, Deirdre Somers, Matthew Campobasso, Neal Pawar, Oleg Movchan, Stephen Malherbe, Tarek Hammoud, and Valeria Gutowski. Learn more on insiders at ENFN. What percentage of Enfusion stock is owned by insiders? 36.44% of Enfusion stock is owned by insiders. Learn more on ENFN's insider holdings. Which Enfusion insiders have been selling company stock? The following insiders have sold ENFN shares in the last 24 months: Bradley Herring ($18,441.54), Bronwen Bastone ($238,784.56), Dan Groman ($514,740.06), Deirdre Somers ($54,194.10), Matthew Campobasso ($24,820.37), Neal Pawar ($218,664.03), Oleg Movchan ($2,526,452.85), Stephen Malherbe ($21,210,000.00), Tarek Hammoud ($10,700,000.00), and Valeria Gutowski ($10,513.57). How much insider selling is happening at Enfusion? Insiders have sold a total of 3,370,354 Enfusion shares in the last 24 months for a total of $35,516,611.08 sold. Enfusion Key ExecutivesMr. Oleg Movchan (Age 49)CEO & Director Compensation: $834.79kMr. Bradley Herring (Age 53)Chief Financial Officer Compensation: $574.12kMr. Neal Pawar (Age 52)Chief Operating Officer Compensation: $469.39k1 recent tradesMr. Stephen MalherbeManaging PartnerMs. Valeria Gutowski (Age 42)Chief Accounting Officer Mr. Daniel Groman (Age 35)Chief Technology Officer Mr. Ignatius Tochukwu NjokuHead of Investor RelationsMr. Matthew R. Campobasso (Age 45)General Counsel & Corporate Secretary 1 recent tradesMs. Bronwen Bastone (Age 51)Chief People Officer Compensation: $566.25kMr. Joseph DefeoGlobal Head of Managed Services Production More Insider Trading Tools from MarketBeat Related Companies C3.ai Insider Transactions Qualys Insider Transactions Varonis Systems Insider Transactions Intapp Insider Transactions Freshworks Insider Transactions Zeta Global Insider Transactions Tenable Insider Transactions BOX Insider Transactions Braze Insider Transactions nCino Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NYSE:ENFN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.